MAGGIE BISTODEAU: Open Payments
NPI 1407524622 · TEA, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 22 payments from 12 companies in 2025. Trend: 2023 $288 · 2024 $416 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $97 |
| Amgen Inc. | 3 | $59 |
| PFIZER INC. | 3 | $53 |
| Lilly USA, LLC | 3 | $48 |
| Actelion Pharmaceuticals US, Inc. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 2 | $20 |
| Novo Nordisk Inc | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| Corium, LLC | 1 | $17 |
Products named: QULIPTA, NURTEC ODT, MOUNJARO, REPATHA, UPTRAVI, UBRELVY, LEQVIO, VOQUEZNA.
Industry payments across SD — which companies pay providers there.
